Literature DB >> 23353081

History of scorpion antivenom: one Arizonan's view.

Leslie Boyer1.   

Abstract

This paper was originally presented as the Elsevier Lecture in July, 2012 at the International Society on Toxinology/Venom Week combined meeting in Honolulu, Hawaii. In it, the author addresses the ancient history of venom and immunity, from the Silurian Era to the 1890s; the development of the first antivenoms; the impact of shifting political and economic pressures; the special case of Arizona; the relative stability of the 1960s through 1990s; the transition to regulatory compliance that took place at the time of the author's own research; and concluding thoughts regarding the instability of apparent success.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23353081     DOI: 10.1016/j.toxicon.2012.12.015

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  4 in total

1.  Study of Factors Contributing to Scorpion Envenomation in Arizona.

Authors:  Bethany K Bennett; Keith J Boesen; Sharyn A Welch; A Min Kang
Journal:  J Med Toxicol       Date:  2018-11-28

2.  A clinical trial protocol to treat massive Africanized honeybee (Apis mellifera) attack with a new apilic antivenom.

Authors:  Alexandre Naime Barbosa; Leslie Boyer; Jean-Philippe Chippaux; Natalia Bronzatto Medolago; Carlos Antonio Caramori; Ariane Gomes Paixão; João Paulo Vasconcelos Poli; Mônica Bannwart Mendes; Lucilene Delazari Dos Santos; Rui Seabra Ferreira; Benedito Barraviera
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-03-16

Review 3.  Diagnostic and Therapeutic Value of Aptamers in Envenomation Cases.

Authors:  Steven Ascoët; Michel De Waard
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

Review 4.  History of Envenoming Therapy and Current Perspectives.

Authors:  Manuela B Pucca; Felipe A Cerni; Rahel Janke; Erick Bermúdez-Méndez; Line Ledsgaard; José E Barbosa; Andreas H Laustsen
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.